Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-31falsefalsefalse2024-04-01No description of principal activity22The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 10832779 2024-04-01 2025-03-31 10832779 2023-04-01 2024-03-31 10832779 2025-03-31 10832779 2024-03-31 10832779 c:Director2 2024-04-01 2025-03-31 10832779 d:CurrentFinancialInstruments 2025-03-31 10832779 d:CurrentFinancialInstruments 2024-03-31 10832779 d:Non-currentFinancialInstruments 2025-03-31 10832779 d:Non-currentFinancialInstruments 2024-03-31 10832779 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 10832779 c:FullAccounts 2024-04-01 2025-03-31 10832779 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10832779 c:Micro-entities 2024-04-01 2025-03-31 10832779 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Registered number: 10832779









KKS PHARMA ENTERPRISE LTD







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2025

 
KKS PHARMA ENTERPRISE LTD
REGISTERED NUMBER: 10832779

BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
£
£


Fixed assets
165,000
165,000

Current assets
3,270
9,106

Creditors: amounts falling due within one year
(76,813)
(75,085)

Net current liabilities
 
 
(73,543)
 
 
(65,979)

Total assets less current liabilities
91,457
99,021

Creditors: amounts falling due after more than one year
(77,874)
(86,178)


Net assets
13,583
12,843



Capital and reserves
13,583
12,843


Notes


General information

KKS Pharma Enterprise Ltd is a private company, limited by shares, registered in England and Wales. The address of the Company’s registered office is 3 Gables, Corner Hall, Hemel Hempstead, Hertfordshire, HP3 9HN.
The financial statements are presented in sterling which is the functional currency of the Company and rounded to the nearest £.


Average number of employees

The average monthly number of employees, including directors, during the year was 2 (2024 - 2).


Directors' confirmations

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Page 1

 
KKS PHARMA ENTERPRISE LTD
REGISTERED NUMBER: 10832779
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
S Patel
Director
Date: 10 November 2025

 
Page 2